Alzheimer's Drug Donanemab

An experimental Alzheimer’s drug, donanemab, was endorsed by a U.S. Food and Drug Administration advisory panel. The drug is designed to treat symptoms of early Alzheimer’s disease and has shown promising results in clinical trials.